Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
S&S Healthcare HoldingROCO:4198 -5.11%54 PB Ratio is 4.05 as of Jul. 19, 2026, which is 6% above its 10-year median of 3.82. GuruFocus rates ROCO:4198 with a GF Score™ of 54/100 and a GF Value™ of NT$23.68 (Significantly Overvalued). The stock has 1 warning sign investors should review. Among 786 Medical Devices & Instruments companies, S&S Healthcare Holding ranks worse than 75.57% on this metric.
The historical rank and industry rank for S&S Healthcare Holding's PB Ratio or its related term are showing as below:
ROCO:4198'
s PB Ratio Range Over the Past 10 Years
Min: 0.85 Med: 3.82 Max: 1442.5
Current: 4.05
During the past 13 years, S&S Healthcare Holding's highest PB Ratio was 1442.50. The lowest was 0.85. And the median was 3.82.
ROCO:4198's PB Ratio is ranked worse than 75.57% of 786
companies
in the Medical Devices & Instruments industry
Industry Median: 2.04
vs ROCO:4198: 4.05
During the past 12 months, S&S Healthcare Holding's average Book Value Per Share Growth Rate was -13.20% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 15.40% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 22.70% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was -25.30% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of S&S Healthcare Holding was 46.90% per year. The lowest was -54.40% per year. And the median was -29.80% per year.
Back to Basics: PB Ratio
S&S Healthcare Holding (ROCO:4198) PB Ratio Explanation
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, S&S Healthcare Holding's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
S&S Healthcare Holding PB Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, S&S Healthcare Holding's PB Ratio distribution charts can be found below:
* The bar in red indicates where S&S Healthcare Holding's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
S&S Healthcare Holding (ROCO:4198) has a PB Ratio of 4.05 as of Jul. 19, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on S&S Healthcare Holding and its competitors. This is near median its historical median of 3.82. Over the past decade, S&S Healthcare Holding's PB Ratio has ranged from 0.85 to 1,442.50. According to the industry distribution chart, S&S Healthcare Holding ranks #594 out of 786 companies in the Medical Devices & Instruments industry, placing it in the top 75.6%.
Is S&S Healthcare Holding's PB Ratio too high?
S&S Healthcare Holding's current PB Ratio of 4.05 is near median its 10-year median of 3.82. Over the past 10 years, this metric has ranged from a low of 0.85 to a high of 1,442.50. The Medical Devices & Instruments industry median PB Ratio is 2.04. S&S Healthcare Holding's value of 4.05 is 98.5% above this industry median. Based on the distribution chart, S&S Healthcare Holding ranks #594 out of 786 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, S&S Healthcare Holding has a GF Score™ of 54/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does S&S Healthcare Holding's PB Ratio compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, S&S Healthcare Holding ranks #594 out of 786 companies for PB Ratio. This places S&S Healthcare Holding in the lower half of its industry. The industry median PB Ratio is 2.04. S&S Healthcare Holding's value of 4.05 is 98.5% above this benchmark. Historically, S&S Healthcare Holding's own PB Ratio has ranged from 0.85 to 1,442.50 over the past decade. While the company's 10-year median is 3.82 vs. the industry median of 2.04, S&S Healthcare Holding has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Medical Devices & Instruments company?
The median PB Ratio among Medical Devices & Instruments companies is 2.04, based on 786 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. S&S Healthcare Holding's current PB Ratio of 4.05 is 98.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on S&S Healthcare Holding and its competitors. For the Medical Devices & Instruments industry, the median PB Ratio is 2.04 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. S&S Healthcare Holding's current PB Ratio is 4.05, which is near median its own 10-year median of 3.82. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is S&S Healthcare Holding stock overvalued right now?
Based on GuruFocus' analysis, S&S Healthcare Holding (ROCO:4198) is currently considered Significantly Overvalued. The stock's GF Value™ is NT$23.68, compared to a current price of NT$38.05 — trading 60.7% above its estimated fair value. The current PB Ratio is 4.05, which is near median its 10-year median of 3.82 and 98.5% above the Medical Devices & Instruments industry median of 2.04. S&S Healthcare Holding's overall GF Score™ is 54/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For S&S Healthcare Holding (ROCO:4198), the current PB Ratio is 4.05 as of Jul. 19, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is S&S Healthcare Holding (ROCO:4198) Overvalued in 2026?
Based on GuruFocus' analysis, S&S Healthcare Holding stock appears to be overvalued.
The current stock price of NT$38.05 is trading 60.7% above its estimated GF Value™ of NT$23.68.
GuruFocus considers S&S Healthcare Holding to be Significantly Overvalued.
Key valuation signals for ROCO:4198:
PB Ratio: 4.05 (near median its 10-year median of 3.82)
GF Value™: NT$23.68 vs. price of NT$38.05 (60.7% above fair value)
Industry Position: 98.5% above the Medical Devices & Instruments median (#594 of 786)
No single metric tells the full story. See the ROCO:4198 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
S&S Healthcare Holding Ltd, formerly Swissray Global Healthcare Holding Ltd is involved in providing DR systems designed for any application in general radiography. The product divisions of the company cover Swissray DDR systems, Novadaq, and EZ2GO. The main business projects of the company and its subsidiaries are the research and development, manufacturing, sales, and maintenance services of high-end medical equipment and the manufacturing and sales of basic medical equipment.
54GF Score
Get the complete analysis for ROCO:4198
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:4198 has been successfully added to your 
